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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of evidence. 
Equity-focused approaches to learning loss during COVID-19 
Mundy, K & Hares, S | Center for Global Development | 16 April 2020 | Blog 
https://www.cgdev.org/blog/equity-focused-approaches-learning-loss-during-covid-19 
COVID-19 “presents an especially stark equity challenge” in developing countries. This blog draws 
on a wide range of evidence about interventions that hold promise as equity-focused approaches 
to learning continuity. Emergency measures relying solely on technology will be an inadequate 
response for children who are most left behind by current policies. This blog points to remote 
learning opportunities for children without connectivity. Interventions are likely to make modest 
contributions – their primary role may be to keep children engaged in their education. This blog 
urges ministries of education to start planning now to implement targeted accelerated learning 
measures to ensure children from the poorest households can catch up when schools reopen. 
Advocacy and action by people with disabilities about COVID-19 
Dean et al. | ARISE Consortium | 16 April 2020 | Third blog of Twitter chat on Disability and 
COVID-19 
http://www.ariseconsortium.org/advocacy-and-action-by-people-with-disabilities-about-covid-19-
coronavirus/ 
This is the third blog of a series of learnings from the Twitter Chat on 6 April, hosted by ARISE on 
Disability and COVID-19 bringing together people with disabilities, disabled persons organisations, 
NGOs, and other experts from around the world. This blog focuses on advocacy and action that 
should be led by people with disabilities to promote change and collective action on COVID-19. 
Messaging should not be “for” but “by” people with disabilities and these people, along with 
disability experts, should be included in, and working with, agencies managing the response. 
Includes principles and priorities for inclusion, guidance documents on inclusion and advocacy and 
a note on exercising caution in language used. 
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COVID-19 in patients with HIV: clinical case series 
Blanco et al. | The Lancet HIV | 15 April 2020 | Correspondence 
https://doi.org/10.1016/S2352-3018(20)30111-9 
This Correspondence reports on demographics and baseline HIV status, clinical findings on 
admission and antiviral and antiretroviral treatment and outcomes of five COVID-19 patients with 
HIV-1 in a hospital in Barcelona, Spain. Previously COVID-19 has been described in only one 
patient with HIV in Wuhan, China. 
Smell and taste dysfunction in patients with COVID-19 
Xydakis et al. | The Lancet Infectious Diseases | 15 April 2020 | Correspondence 
https://doi.org/10.1016/S1473-3099(20)30293-0 
Observations are increasing from front-line healthcare workers that anosmia, (loss of sense of 
smell), with or without dysgeusia (loss of taste), are symptoms frequently associated with SARS-
CoV-2 infection. Whilst evidence still lacks on this, the America Academy of Otolaryngology- Head 
and Neck Surgery and the British Association of Otorhinolaryngology are now recommending 
these symptoms be added to the list of primary screening symptoms for COVID-19.Clinicians have 
also observed that anosmia, with or without dysgeusia, manifests early in the disease process or 
in patients with mild or no constitutional symptoms. SARS-CoV-2 also does not appear to generate 
clinically significant nasal congestion or rhinorrhoea. 
Enteric involvement in hospitalised patients with COVDI-19 outside Wuhan 
Wan et al. | The Lancet Gastroenterology & Hepatology | 15 April 2020 | Correspondence 
https://doi.org/10.1016/S2468-1253(20)30118-7 
Evidence for enteric involvement is emerging. This study examined the intestinal symptoms of 230 
patients with COVID-19 from multiple medical centres located in and outside of Hubei province. 
The most common symptoms at onset of illness were fever (84%), cough (69%) and sputum 
production (43%). Diarrhoea was also observed in 21% of patients with a greater proportion of 
patients admitted to hospital with diarrhoea as the outbreak progressed 9 (43%) patients admitted 
12 Feb to 6 March compared to 40 (19%) patients admitted between 19 Jan and 11 Feb 2020. 
There was a correlation between the presence of diarrhoea and the severity of respiratory 
symptoms and found that more patients with diarrhoea required ventilator support and were 
admitted to intensive care than those without diarrhoea, similar to SARS outbreak in 2003. Note 
that there is an absence of data on the prevalence of asymptomatic COVID-19 and that the 
antivirals, lopinavir and ritonavir, are known to cause diarrhoea – although in this study no 
correlation was observed between diarrhoea and use of antivirals. 
Centre of Evidence Based Dermatology 
University of Nottingham | Resource 
https://www.nottingham.ac.uk/research/groups/cebd/resources/coronavirus-resource/journal-
articles.aspx 
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This resource lists journal articles on coronavirus with relevance for skin diseases and 
dermatology. 
How is COVID-19 affecting malaria programs? 
Ravelo, JL | Inside Development Devex 15 April 2020 | Blog 
https://www.devex.com/news/how-is-covid-19-affecting-malaria-programs-96992 
This blog highlights recent guidance published by the Alliance for Malaria Prevention placing 
importance on vector control activities in countries with active malaria transmission whilst 
maintaining the health and welfare of staff involved with these campaigns. But lockdowns, travel 
bans and movement restrictions of health workers are causing some supply chain disruptions 
essential in preparing ahead of monsoon season. Concerns are also raised that, while it has yet 
to be proven through clinical trials underway that hydroxychloroquine and chloroquine anti-malarial 
drugs are safe and effective for COVID-19 treatment, governments have started placing large 
orders of these drugs and a surge in demand could lead to shortages and availability for those who 
need it. 
Countries facing COVID-19 debt need flexible financing: lessons from China 
Chen Y. | ODI | 14 April 2020 | Blog 
https://www.odi.org/blogs/16842-countries-facing-covid-19-debt-need-flexible-financing-lessons-
china? 
This blog argues for greater flexibility from both traditional and non-traditional lenders, such as 
China, from all responsible development partners – transparent and co-ordinated debt relief 
initiatives to address the immediate economic and fiscal impacts of COVID-19. 
After the pandemic: How will COVID-19 transform global health and development? 
Igoe, M. & Chadwick, V | Inside Development Devex | 13 April 2020 | News 
https://www.devex.com/news/after-the-pandemic-how-will-covid-19-transform-global-health-and-
development-96936 
Twenty-one global health and development thinkers and leaders were asked for their insights and 
their predictions of the big-picture long-term consequences of the pandemic – how it will reshape 
health and development institutions, occupations, and priorities.  
Mobile applications to support contact tracing in the EU’s fight against COVID-19: 
Common EU Toolbox for Member States version 1.0 
e-Health Network | 15 April 2020 | Toolbox 
https://ec.europa.eu/health/sites/health/files/ehealth/docs/covid-19_apps_en.pdf 
A toolbox developed by the e-Health Network with support of the European Commission, is 
intended as a practical guide to implementing digital tools for tracking close contacts between 
device carriers as a proxy for infection risk whilst considering privacy, data protection, 
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anonymisation, security, effectiveness, voluntary, being required for only as long as needed and 
coordinated and approved by public health authorities. 
Apple and Google are working together on technology for coronavirus contact tracing 
Nellis, S. & Dave, P. | WEF & Reuters | 11 April 2020 | News 
https://www.weforum.org/agenda/2020/04/apple-google-working-technology-for-coronavirus-
contact-tracing 
Article on contact tracing smartphone apps including Apple and Google’s efforts. Includes an 
Image of what TraceTogether is and how it works – the contact tracing app already used in 
Singapore. 
How social protection can help countries cope with COVID-19 
Rutkowski, M | World Bank | 15 April 2020 | Blog 
https://blogs.worldbank.org/voices/how-social-protection-can-help-countries-cope-covid-
19?cid=EXT_WBBlogTweetableShare_D_EXT 
Social Protection and Jobs Responses to COVID-19: A real-time review of country 
measures 
Gentilini, U (WB), Almenfi M (WB), Orton I (ILO) and Dale P (UNICEF) | 10 April 2020 | “Living 
paper” version 4 
http://www.ugogentilini.net/wp-content/uploads/2020/04/Country-SP-COVID-
responses_April10.pdf 
This weekly blog, issued every Friday, provides updates on how countries are using social 
protection programmes for responding to COVID-19. This is the latest one. 
Online learning and events 
Emerging respiratory viruses, including COVID-19: methods for detection, prevention, 
response and control 
WHO | Free | 3 hours duration  
https://openwho.org/courses/introduction-to-ncov 
A general introduction to enable you to describe the fundamental principles of emerging respiratory 
viruses, including novel coronaviruses, and how to effectively respond to an outbreak. Intended for 
public health professionals, incident managers and personnel working for the UN, international 
organisations and NGOs. 
Responding to COVID-19: Real-time training for the coronavirus disease outbreak 
WHO | Available now | multiple self-paced courses 
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https://openwho.org/channels/covid-19 
Note that courses are available in English and other languages including French, Portuguese 
and Spanish. 
COVID-19: Tackling the Novel Coronavirus 
LSHTM | FutureLearn course | Starts 25 May 2020 | 3 weeks | 4 hours weekly study | Free 
https://www.futurelearn.com/courses/covid19-novel-coronavirus 
Unfacilitated access to this course remains. An updated version of this course will though be run 
from 25 May 2020. On this course you will learn what is known about the outbreak of COVID-19 
(week 1); what the practical implications for responding to COVID-19 are (week 2); and what we 
need to find out about COVID-19 (week 3). 
COVID-19 Diagnostics and Testing 
FIND, LSHTM & ASLM | FutureLearn course | Starts 20 April 2020 | 3 weeks | 3 hours weekly 
study | Free 
https://www.futurelearn.com/courses/covid-19-diagnostics-and-testing 
This course is designed for professionals involved in the testing and diagnosis of COVID-19, with 
a focus on low- and middle-income settings. You will learn the latest recommendations on COVID-
19 testing, get upt0date information on the performance of tests and how best to deploy them. 
COVID-19 Critical Care: Understanding and Application 
University of Edinburgh & Royal College of Physicians of Edinburgh  | FutureLearn course | 
Starts 6 April 2020 | 5 weeks | 1 hour weekly study | Free 
https://www.futurelearn.com/courses/covid-19-critical-care-education-resource 
Designed for frontline clinical staff to learn the principles and practice of critical care to treat and 
care for critically ill patients during the COVID-19 pandemic. You will learn (1) how to apply the 
current and evolving principles of PPE in the care of COVID-19; (2) apply evidence-based 
principles of advanced organ support and monitoring to the COVID-19 critically ill patients; (3) 
apply evidence-based daily practices to care of the critically ill patient; and (4) develop a range of 
specialised self-caring practices. 
Note that this resource has been created in response to the COVID-19 emergency and does not 
correspond to the classic structure of a FutureLearn course. You do not have to follow the week 
by week approach and can select the materials most relevant to your work. 
Tracking Dashboards 
Global    
WHO sitreps 
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Johns Hopkins University 
WEF 
Vaccine Centre LSHTM 
Our World in Data 
Global 5050 
Humanitarian Data Exchange 
Information is Beautiful 
The Commons Project 
Regional 
WHO Africa 
African Arguments 
European CDC 
Country 
Ghana 
Indonesia 
Sierra Leone 
Singapore 
UK 
US 
Guidelines 
Global WHO 
Regional Africa CDC 
Country Nigeria CDC 
 UK Government 
 UK ONS 
 NICE UK 
 US CDC 
Resource Hubs 
Multilaterals WHO 
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 WHO risk communication 
 WHO Q&A 
 
WHO Global research 
COVID-19 Solidarity Response Fund 
 UN 
 UN Women 
 
UNOCHA 
UNHCR 
 UNICEF 
 UNESCO 
 UN WFP 
 World Bank 
Regional & Country 
  
Africa CDC 
African Union 
Academic journals The Lancet 
 NEJM 
 Elsevier 
 BMJ 
 Cell 
 PLoS 
 Cochrane reviews 
Global Health Institutes LSTM 
 LSHTM 
 Johns Hopkins University 
 ICL MRC Centre for Global Infectious Disease Analysis 
 ODI 
 Norwegian Institute of Public Health 
Ethics Rings HSG Resyst Reach Wellcome 
Clinical trials US NIH registered clinical trials 
Funding bodies UKRI 
 Wellcome 
Demographics WorldPop 
Global Impact Surveys Premise COVID-19 Global Impact Study 
 GeoPoll: SSA 
TB Stop TB Partnership 
Disability IDA 
 Disability and inclusion 
 Coregroup IDDC  
SDGs Global Partnership for Sustainable Development Data 
Humanitarian Reliefweb 
 Humanitarian OpenStreetMap Team 
 SSHAP 
Narratives David Nabarro, WHO DG Special Envoy on COVID-19 
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